Effective gene transfer of lacZ and P0 into Schwann cells of P0‐deficient mice

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Glia

• Publication date

  1999-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-1136(19990115)25:2<165::AID-GLIA7>3.0.CO;2-LPMID 9890631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene transfer to schwann cells after peripheral nerve injury: A delivery system for therapeutic agents

  1998cited by this paper
• Many facets of the peripheral myelin protein PMP22 in myelination and disease

  1998cited by this paper
• Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies

  1998cited by this paper
• Lymphocyte Recruitment Following Spinal Cord Injury in Mice is Altered by Prior Viral Exposure

  1997cited by this paper
• Myelin: keeping nerves well wrapped up.

  1997cited by this paper
• Recombinant adenovirus: a gene transfer vector for study and treatment of CNS diseases.

  1997cited by this paper
• Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules

  1997cited by this paper
• Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst

  1997cited by this paper
• The biology and pathobiology of Schwann cells.

  1997cited by this paper
• Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS.

  1997cited by this paper
• Gene transfer by adeno-associated virus vectors into the central nervous system.

  1997cited by this paper
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

  1997cited by this paper
• Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies.

  1997cited by this paper
• Animal models for inherited peripheral neuropathies

  1997cited by this paper
• The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation.

  1996cited by this paper
• Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral Vectors

  1996cited by this paper
• Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy

  1996cited by this paper
• Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

  1996cited by this paper
• Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination.

  1996cited by this paper
• The Transcription Factors SCIP and Krox-20 Mark Distinct Stages and Cell Fates in Schwann Cell Differentiation

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Viral vectors for modulating gene expression in neurons.

  1996cited by this paper
• Immune responses to adenovirus vectors in the nervous system.

  1996cited by this paper
• Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector.

  1996cited by this paper
• The proteolipid protein gene: double, double, ... and trouble.

  1996cited by this paper
• Myelin mutants: Model systems for the study of normal and abnormal myelination

  1996cited by this paper
• Two divergent types of nerve pathology in patients with different P sub 0 mutations in Charcot-Marie-Tooth disease

  1996cited by this paper
• Onion bulb cells in mice deficient for myelin genes share molecular properties with immature, differentiated non‐myelinating, and denervated Schwann cells

  1996cited by this paper
• The principles of gene therapy for the nervous system.

  1996cited by this paper
• Functional abnormalities in P0‐deficient mice resemble human hereditary neuropathies linked to P0 gene mutations

  1996cited by this paper
• Immunophilins and nervous system

  1995cited by this paper
• FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene Transfer

  1995cited by this paper
• Biology and genetics of hereditary motor and sensory neuropathies.

  1995cited by this paper
• Adenovirus gene transfer causes inflammation in the brain.

  1995cited by this paper
• Immunophilins and the nervous system.

  1995cited by this paper
• Protein zero (P0)–deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies

  1995cited by this paper
• Gene therapy in the central nervous system: Direct versus indirect gene delivery

  1995cited by this paper
• Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin

  1995cited by this paper
• Myelin genes: getting the dosage right

  1995cited by this paper
• An adenoviral vector can transfer lacZ expression into schwann cells in culture and in sciatic nerve

  1995cited by this paper
• Genetic control of host resistance to infection.

  1994cited by this paper
• Krox-20 controls myelination in the peripheral nervous system

  1994cited by this paper
• Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease.

  1994cited by this paper
• Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot–Marie–Tooth disease type 1B

  1993cited by this paper
• Transfer of a foreign gene into the brain using adenovirus vectors

  1993cited by this paper
• An adenovirus vector for gene transfer into neurons and glia in the brain

  1993cited by this paper
• Charcot–Marie–Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene

  1993cited by this paper
• A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

  1993cited by this paper
• Expression of tenascin in the developing and adult cerebellar cortex

  1992cited by this paper
• Widespread long-term gene transfer to mouse skeletal muscles and heart.

  1992cited by this paper
• Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons.

  1992cited by this paper
• The protein product of the zebrafish homologue of the mouse T gene is expressed in nuclei of the germ ring and the notochord of the early embryo.

  1992cited by this paper
• Manipulation of adenovirus vectors.

  1991cited by this paper
• Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts.

  1987cited by this paper
• Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus

  1982cited by this paper
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage

  1981cited by this paper
• Two subsets of rat T lymphocytes defined with monoclonal antibodies

  1980cited by this paper

• Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury

  2022cites this paper
• Gene Therapy for CMT Inherited Neuropathy

  2019cites this paper
• In Vivo Introduction of Transgenes into Mouse Sciatic Nerve Cells Using Viral Vectors.

  2018cites this paper
• Intraneural GJB1 gene delivery improves nerve pathology in a model of X‐linked Charcot–Marie–Tooth disease

  2015cites this paper
• Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1–9 and lentiviral vectors

  2015cites this paper
• In vivo introduction of transgenes into mouse sciatic nerve cells in situ using viral vectors

  2014cites this paper
• Gene therapy approaches to enhance regeneration of the injured peripheral nerve.

  2013cites this paper
• Gene therapy for the peripheral nervous system: a strategy to repair the injured nerve?

  2011cites this paper
• Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration

  2010cites this paper
• Charcot-Marie-Tooth neuropathies: diagnosis and management.

  2008cites this paper
• P120 catenin is required for thickening of Schwann cell myelin.

  2007cites this paper
• Therapeutic strategies for the inherited neuropathies

  2007cites this paper
• Cellular and gene therapies for the enhancement of peripheral nerve regeneration through bio-engineered nerve conduits

  2007cites this paper
• The therapeutic potential of gene transfer for the treatment of peripheral neuropathies

  2007influential citation
• Medical treatment of hereditary neuropathies

  2005cites this paper
• Neuropathies—Translating Causes into Treatments

  2005cites this paper
• Adherens Junctions in Myelinating Schwann Cells Stabilize Schmidt-Lanterman Incisures via Recruitment of p120 Catenin to E-Cadherin

  2005cites this paper
• Green Fluorescent Protein Is a Stable Morphological Marker for Schwann Cell Transplants in Bioengineered Nerve Conduits

  2004cites this paper
• Molekulare Variabilität der monogenen peripheren Neuropathien

  2003cites this paper
• Adenovirus and Adeno-Associated Virus Vectors

  2002cites this paper
• A Novel Use of Alginate Hydrogel as Schwann Cell Matrix

  2001cites this paper
• P0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading.

  2001cites this paper
• Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.

  2001cites this paper
• Retroviral labeling of Schwann cells: In vitro characterization and in vivo transplantation to improve peripheral nerve regeneration

  2001cites this paper
• P0 Glycoprotein Overexpression Causes Congenital Hypomyelination of Peripheral Nerves

  2000cites this paper
• P0 protein peptide 180‐199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice

  2000cites this paper
• Long-term Effect of Vital Labelling on Mixed Schwann Cell Cultures

  2000cites this paper
• Animal models for inherited peripheral neuropathies

  2000cites this paper
• 5th Workshop of the European CMT Consortium, 69th ENMC International Workshop: therapeutic approaches in CMT neuropathies and related disorders 23-25 April 1999, Soestduinen, The Netherlands.

  2000cites this paper
• PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.

  2000cites this paper
• Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.

  2000cites this paper
• Immune Deficiency in Mouse Models for Inherited Peripheral Neuropathies Leads to Improved Myelin Maintenance

  2000cites this paper
• Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance.

  2000cites this paper